PRNP and prion disease: Since mouse experiments with the human V127 PrP variant suggests dosage effects in which optimized protection is observed with increasing expression of the variant vs. wild-type allele [20], it is possible that a successful gene therapy approach against prion disease would require a combination of methods [24].